Proadrenomedullin (1-20), human is a potent hypotensive and catecholamine release–inhibitory peptide released from chromaffin cells with an IC50 of ~350 nM for catecholamine secretion in PC12 pheochromocytoma cells, acting in a noncompetitive manner specifically at the nicotinic cholinergic receptor.
Proadrenomedullin (1-20), human is a synthetic peptide fragment derived from the N-terminal region of the human proadrenomedullin precursor protein. As a bioactive peptide, it represents a key segment involved in the maturation and signaling of adrenomedullin, a multifunctional regulatory peptide implicated in cardiovascular homeostasis, vasodilation, and cellular signaling pathways. The (1-20) fragment is of significant interest in peptide research due to its unique sequence and potential modulatory effects distinct from the mature adrenomedullin peptide. Researchers utilize this fragment to explore the biochemical properties, receptor interactions, and physiological relevance of proadrenomedullin-derived peptides, making it a valuable tool for advancing understanding in peptide biology and signal transduction.
Peptide structure-function analysis: Proadrenomedullin (1-20) serves as a model substrate for investigating the structural determinants that govern the biological activity of proadrenomedullin-derived peptides. By comparing the activity and receptor binding characteristics of the (1-20) fragment with other segments or full-length adrenomedullin, researchers can elucidate the roles of specific amino acid motifs in mediating peptide-receptor interactions. Such studies provide critical insights into the domains responsible for bioactivity, informing the design of novel peptide analogs or inhibitors for basic research applications.
Receptor binding studies: The (1-20) peptide fragment is widely used in in vitro assays to characterize its affinity and specificity for adrenomedullin receptors and related G protein-coupled receptors. Through radioligand binding assays, surface plasmon resonance, and competitive displacement experiments, scientists can map the interaction profile of this peptide with various receptor subtypes. These investigations are essential for understanding the molecular mechanisms underlying peptide-receptor recognition, signal initiation, and downstream cellular responses.
Cell signaling pathway research: Utilization of the human proadrenomedullin (1-20) fragment enables detailed examination of intracellular signaling cascades triggered by proadrenomedullin-derived peptides. By applying this peptide to cultured cells, researchers can monitor activation or inhibition of second messenger systems, phosphorylation events, and transcriptional responses. Such studies reveal how the (1-20) region modulates cellular processes distinct from those induced by mature adrenomedullin, offering new perspectives on peptide-mediated regulation of cell function.
Peptide processing and maturation studies: The (1-20) fragment is instrumental in elucidating the enzymatic pathways responsible for the post-translational processing of proadrenomedullin. By tracking the cleavage, modification, and release of the N-terminal segment in biochemical assays, scientists gain a deeper understanding of how precursor proteins are converted into their active forms. This knowledge is vital for mapping the biosynthetic routes of regulatory peptides and for identifying potential regulatory checkpoints in peptide maturation.
Analytical method development: In the context of peptide quantification and detection, proadrenomedullin (1-20) is often employed as a reference standard or calibration peptide in mass spectrometry, high-performance liquid chromatography, and immunoassay platforms. Its defined sequence and physicochemical properties make it suitable for validating analytical protocols, optimizing detection sensitivity, and ensuring reproducibility in peptide measurement workflows. Through such applications, the fragment supports the advancement of robust analytical methods in peptide research and biomarker discovery.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More